Upping the Dose in Alzheimer's?Dr. Jeffrey Cummings discusses exciting new findings in AD diagnostics and therapeutics presented at this year's American Academy of Neurology Annual Meeting.
Six Years in the Making: New Episodic Migraine GuidelinesWhat herb has level A evidence for migraine relief? What drug is commonly underdosed? Find out as Dr. Andrew Wilner interviews Dr. David Dodick about the AAN's new migraine clinical guidelines.
Medscape Neurology, May 15, 2012
Top News From AAN 2012: SlideshowHighlights from the meeting include a new guideline for the prevention of episodic migraine, more positive results with BG-12 for MS, and the IMS 3 stroke trial was halted.
Should Doctors Invest in Facebook?Investors often kick themselves for not having grabbed the opportunity to invest early in Microsoft or other companies that skyrocketed. Could Facebook be the same type of opportunity?
What Would Healthcare Be Like Under 'President Romney'?The Presidential election is months away, but physicians, consumers, and politicians are speculating on changes Mitt Romney might make to our current healthcare system. Here are some possibilities.
Medscape Business of Medicine, May 2012
Medscape's Best Places to PracticeLooking for a great place to practice medicine? You've got some terrific options. We analyzed physician density, malpractice coverage, insurance competition, medical board activity, insurance mix, income taxes, and cost of living in all 50 US states and the District of Columbia and come up with a list of the best -- and the worst -- states to practice in each region.
Medscape Features Slideshows, May 2012
More Patients, More Revenue, but Less Rush. How?Doctors may think the only way to increase revenue is to add services, do more marketing, and change their practice. But there are ways to make more money by adapting what you're already doing. Here's how.
Medscape Business of Medicine, May 2012
of
Neurology News
– From Medscape Medical News, theheart.org, and more
ESCIST-3: Thrombolysis Benefits Even Oldest Stroke PatientsNew IST-3 trial results show that stroke patients who received tPA benefit in terms of survival and independent living at 6 months compared with controls, regardless of age or stroke severity.
Medscape Medical News, June 1, 2012
CMS Calls for 15% Cut in Antipsychotic Use in Nursing HomesA partnership of regulators, physicians, and advocacy groups has laid out a plan to improve training, and 'increase transparency' about use of antipsychotics in residents without psychosis.
